Pemigatinib
Ended Awarded
- Contract number
- 36C26124N0749
- Awardee
-
Incyte Corporation UEI ZTM9U2G5VTK8
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $119,619
Award facts
- Contract value 100% obligated
- $119,618.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Wilmington, DE 19803, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 21 of the U.S. Department of Veterans Affairs (VA) to Incyte Corporation for the supply of the pharmaceutical drug Pemigatinib, marketed as Pemazyre. The $119,618.73 contract provides for the delivery of this anti-cancer medication to VA medical facilities across the country to support healthcare services for eligible veterans. Incyte, a global biopharmaceutical company, holds two major contract vehicles with the VA - a $541 million Federal Supply Schedule for pharmaceuticals and a $3.75 million Blanket Purchase Agreement specifically for Pemazyre. This allows the VA and other federal agencies to acquire Incyte's drug therapies through pre-competed contract terms. No set-aside designations were used for this particular award.
Quick answers
Who was awarded contract 36C26124N0749?
36C26124N0749 was awarded to Incyte Corporation by Veterans Integrated Service Network 21 (Veterans Health Administration) on July 2, 2024.
How much is contract 36C26124N0749 worth?
The government has obligated $119,619 on 36C26124N0749.
Is contract 36C26124N0749 an order under another contract?
Yes. 36C26124N0749 is a delivery order under 36F79720D0189, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0749 competed?
The extent of competition for 36C26124N0749 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award